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Abstract
Objectives: Behaviours associated with agitation are common in people living with dementia. The Cohen-
Mansﬁeld Agitation Inventory (CMAI) is a 29-item scale widely used to assess agitation completed by a proxy
(family carer or staff member). However, proxy informants introduce possible reporting bias when blinding to
the treatment arm is not possible, and potential accuracy issues due to irregular contact between the proxy and
the person with dementia over the reporting period. An observational measure completed by a blinded
researcher may address these issues, but no agitation measures with comparable items exist.
Design: Development and validation of an observational version of the CMAI (CMAI-O), to assess its validity as
an alternative or complementary measure of agitation with dementia. Two observational measures (CMAI-O
and PAS) were completed by an independent researcher. Measures of agitation, functional status, and
neuropsychiatric symptoms were completed with staff proxies. The CMAI-O showed adequate internal
consistency (α= .61), criterion validity with the PAS (r= .79, p =<.001), incremental validity in predicting
quality of life beyond the Functional Assessment Staging of Alzheimer’s disease (β= 1.83, p < .001 at baseline)
and discriminant validity from the Neuropsychiatric Inventory Apathy subscale (r= .004, p = .902). The
CMAI-O is a promising research tool for independently measuring agitation in people with dementia in care
homes. Its use alongside the CMAI could provide a more robust understanding of agitation amongst residents
with dementia.
Key words: dementia, agitation, observation, care homes, proxy bias
Behaviours associated with agitation are common
amongst people living with dementia, particularly
in care home settings with prevalence estimates of
clinically signiﬁcant symptoms ranging from 40 to
85% in various countries including the UK,Norway,
and Holland (Livingston et al., 2017; Testad et al.,
2007; Zuidema et al., 2007). The aetiology of agita-
tion is not clear but is likely to be multifactorial
with care approaches, the physical and social envi-
ronment, medical comorbidities such as pain, genet-
ics and the progression of dementia pathology all
being contributing factors (Lanctôt et al., 2017).
Consistent with its multifactorial aetiology, there are
many behaviours typically associated with agitation
including repetitive mannerisms, hoarding, scream-
ing, hitting, wandering, verbal aggression, and gen-
eral restlessness, which can be extremely distressing
to the person with dementia, their carers and others
around them. Recent consensus criteria for agitation
state that symptoms of agitation should: (1) occur in
the context of cognitive impairment of dementia;
(2) be consistent with emotional distress; (3) mani-
fest as excessive motor activity, verbal or physical
aggression; and (4) not be solely attributable to
another disorder (Cummings et al., 2015). While
these criteria provide a useful and much needed
framework for the assessment of agitation, particu-
larly with respect to inclusion in clinical trials, there
is still a need to reﬁne and validate assessment
tools to accurately evaluate agitation as a clinical
outcome.
TheNeuropsychiatric Inventory (NPI; Cummings
et al., 1994) and the Cohen-Mansﬁeld Agitation
Inventory (CMAI; Cohen-Mansﬁeld and Billig,
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1986) are both commonly used to evaluate agitation.
The CMAI consists of 29 items forming four sub-
scales; physically aggressive behaviour (e.g. hitting
others), physically non-aggressive behaviour (e.g. pac-
ing), verbally aggressive (e.g. swearing) and verbally
non-aggressive behaviours (e.g. repetitive sentences).
TheCMAI incorporatesboth the frequencyandsever-
ity of behaviours associated with agitation and allows
the quantiﬁcation of agitated behaviours into a con-
tinuous measure, which is sensitive to change. The
combination of these factors has led to its widespread
use in clinical trials of pharmacological (e.g. Porsteins-
son et al., 2014) and psychosocial interventions (e.g.
Ballard et al., 2018).
Proxy informant interviews to complete outcome
measures have clear beneﬁts for populations of
people with dementia, who are likely to have signiﬁ-
cant cognitive impairment or communication difﬁ-
culties that often make direct interviews difﬁcult
(Moyle et al., 2007). Notable drawbacks include
informant recall/knowledge (due to factors such as
the amount of contact between the proxy and
research participant during the reporting period)
and — in the case of psychosocial interventions —
lack of informant blinding to treatment, both of
which can affect measurement accuracy and increase
the chance of unwanted reporting error. In clinical
trial settings, where there is an increasing number of
clinical trials relating to agitation (e.g. Creese et al.,
2018), and where close attention is being paid to the
accuracy of outcome measurements and minimising
placebo response rates, these drawbacks illustrate
the need to explore alternative and complementary
methods for outcome measurements.
Observational tools are one avenue for addressing
the issues outlined above, as independent observers
(i.e. members of the research team who are not part
of the intervention delivery) are able to remain
blinded to treatment and are not subject to recall
issues. There are a number of observational mea-
sures of agitation in people with dementia (Curyto
et al., 2008, Zeller and Rhoades, 2010). However,
some measure a broader range of behaviours that
include but are not restricted to agitation (Auer
et al., 1996; Beck et al., 1997; McCann et al.,
1997; Morgan and Stewart, 1998; Van Haitsma
et al., 1997), some are not appropriately validated
(Camberg et al., 1999; Cohen-Mansﬁeld et al.,
1989; Yudofsky et al., 1997) or are not validated
speciﬁcally for use with people with dementia.
Others include only a narrow range of agitated
behaviours, such as aggression (e.g. Almvik et al.,
2000; Perlman and Hirdes, 2008), and others are
not available (Whall, 1999).
There are then few observational agitation mea-
sures appropriately validated for use with people
with dementia, which include a range of potential
agitated behaviours. These include the Agitated
Behaviour Scale (ABS; Bogner et al., 1999; Corri-
gan, 1989) and the Pittsburgh Agitation Scale (PAS;
Rosen et al. 1994). However, these too have limita-
tions. The ABS, for example, was originally devel-
oped for use in people with traumatic brain injury,
and some items are relevant only to a hospital rather
than care home environment (e.g. pulling at tubes,
restraints etc). The scale also does not capture
the frequency of occurrence of a particularly behav-
iour over an extended period of time due to the
20-minute observation periods used. The PAS mea-
sures the severity of four groups of agitated beha-
viours and is completed by trained researchers or
clinical staff based on observations of participant
behaviour over a shift or similar extended period
of time. The PAS lacks detail in key areas including
the breadth of symptoms assessed and the frequency
with which symptoms occur. These additional
pieces of information are vital for any assessment
scale to capture heterogeneous range of symptoms
that can constitute an agitated clinical syndrome.
Likewise, due to the different approaches to mea-
surement of agitation, none of the measures are
appropriate for use as a direct comparator measure
to the CMAI to detect potential reporting error by
proxy reporters.
We sought to address these issues by developing
and testing an observational version of the CMAI
and including it in a randomized controlled trial
where the primary outcome measure was resident
agitation measured by the CMAI. This paper pre-
sents data that evaluates the psychometric properties
and reliability of the CMAI-O and its criterion,
incremental, and discriminant validity in compari-
son to existing measures. It also discusses its poten-
tial as an alternative or complementary measure of
agitation in people with dementia. This was achieved
through secondary analysis of the [name redacted]
DCM EPIC trial dataset (see Surr et al., 2016 for
trial protocol).
Method
Participants
Participants [number (N)= 726] were recruited
from 50 randomly selected care homes (mean= 15
residents per care home) in three regions across
England (Yorkshire, Oxfordshire and London) for
a randomized controlled trial. Residents were eligi-
ble to participate if they lived in the care home
permanently and had a formal diagnosis of dementia
or scored ≥ 4 on the Functional Assessment Staging
of Alzheimer’s disease (FAST; Reisberg, 1988).
Residents were ineligible to participate if they had
been formally admitted to an end of life care pathway
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or were cared for in bed. For inclusion in the present
work, participants were required to have the CMAI-
O (completed by an independent observer) com-
pleted for at least 2 hours, and at least one measure
completed by a staff proxy; therefore, the sample
differed at each time point due to loss to follow-up
and missing data.as assessed by their key worker
status and/or the judgement of the home manager)
for at least several months. Additionally, this person
must have been in regular contact with the resident
during the previous 2 weeks. Researchers provided
information on the completion of measures, includ-
ing the period that the staff proxy should consider,
and the use of rating scales.
Where possible, residents provided consent to
participate.Where potential participantswere deemed
not to have capacity, a personal consultee (relative or
friend) was approached to provide advice on the
person’s wishes. For potential participants whose
personal consultee did not respond to contact or
who did not have anyone to act as a personal con-
sultee, a nominated consultee (care staff member) was
approached to provide this advice.
Ethical considerations
Ethical approval for the clinical trial was obtained
from the Bradford Leeds NHS REC committee and
subsequent ethical approval for this sub-study was
obtained from the Leeds Beckett University research
ethics committee. Where possible, residents pro-
vided informed written consent to participate.
Where potential participants were deemed not to
have capacity, in line with the Mental Capacity Act
(2005) and following standard guidance (Medical
Research Council, 2007), a personal consultee (rel-
ative or friend) was approached to provide advice
on the person’s wishes. For potential participants
whose personal consultee did not respond to con-
tact or who did not have anyone to act as a per-
sonal consultee, a nominated consultee (care staff
member) was approached to provide this advice.
For reasons of privacy and dignity, CMAI-O and
PAS observations took place only in the public areas
of the care home (e.g. lounge, dining room, corri-
dors), and no private or personal care, or observa-
tions in bedrooms or bathrooms were conducted.
Measures
Six measures were completed at three time points;
baseline, 6 months post care home randomisation
(ﬁrst follow-up) and 16 months post randomisation
(second follow-up; see Table 1 for an overview). The
independent observer, who was blinded to interven-
tion allocation, conducted observations (of both the
CMAI-O and PAS) between approximately 10am
and 12pm, and 2pm and 5pm, on a single day, to
reach a total of 5 hours observation. All other
measures, completed by a researcher with the staff
proxy, were completed within 4 weeks of the obser-
vational measures.
Researchers were able to act as the independent
observer if they had not previously visited the care
home to consent participants or complete any data
collection. Prior to this, inter-rater reliability with
another researcher of at least 80% agreement on the
CMAI-O over a 1-hour period was required.
COHEN-MANSFIELD AGITATION INVENTORY
The CMAI (Cohen-Mansﬁeld and Billig, 1986)
measures 29 behaviours typically associated with
agitation or aggression. Proxy reporters identify the
frequency of 29 behaviours during the past 2 weeks,
on a seven-point Likert scale ranging from “never”
to “several times an hour”, with higher scores indi-
cating more agitation. The measure has moderate
concurrent validity with NPI-NH Agitation sub-
scale (r= .52; Wood et al., 2000) and converge
with an observational scale of agitation, the Agi-
tated Behaviours Mapping Instrument (r= .32-.39;
Cohen-Mansﬁeld and Libin, 2004). The CMAI
showed internal consistency of α= .85 at baseline.
Table 1. Overview of measures and use within the study
MEASURE
NUMBER
OF ITEMS COMPLETED BY REPORTING PERIOD
FORM OF
VALIDITY/
RELIABILITY
USED TO TEST
...................................................................................................................................................................................................................................................................................................................................
CMAI 29 Researcher with family/staff proxy Previous 2 weeks Criterion
CMAI-O 29 Independent observer Five hours on a single day N/A
PAS 4 Independent observer Five hours on a single day Criterion
NPI-NH 12 (with sub scales) Researcher with staff proxy Previous 2 weeks Criterion
QUALID 11 Researcher with family/staff proxy Previous 7 days Criterion
FAST 7 levels (sub-levels for
levels 6 and 7)
Researcher with staff proxy Not specified Incremental
Validation of the CMAI-O 3
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OBSERVATIONAL COHEN-MANSFIELD AGITATION
INVENTORY (CMAI-O)
The CMAI-O includes the same 29 items as the
CMAI, but completed through observations of the
participant by a trained researcher. The CMAI-O is
scored on a four-point Likert scale of 1= “never”,
2= “less than once per hour”, 3= “once per hour”
and 4= “several times an hour”, with higher scores
indicating more agitation. In the present study, data
were collected across 5 hours split into two time
points during a single day. Up to 15 observations
(individuals) were conducted simultaneously. The
CMAI-O showed internal consistency of α= .61 at
baseline.
PITTSBURGH AGITATION SCALE (PAS)
The PAS (Rosen et al., 1994) is an observational
rating of agitation and was completed by the inde-
pendent observer concurrently with the CMAI-O.
This measures intensity of agitation on four do-
mains; aberrant vocalization (e.g. screaming), motor
agitation (e.g. wandering), aggressiveness, and re-
sisting care, each scored on a ﬁve-point Likert scale
from 0 (not present) to 4 (high intensity of agitated
behaviour). The measures also asks whether any
interventions were used by care staff to support or
manage agitated behaviours e.g. seclusion or re-
straint. PAS observations should be conducted for
between 1 and 8 hours, and in the present study, data
were collected across 5 hours in a single day. The
measure has internal consistency of α= .80 (Rosen
et al., 1994) and in the current study, had internal
consistency of α= .63 at baseline.
THE NEUROPSYCHIATRIC INVENTORY – NURSING
HOME (NPI-NH)
The NPI-NH (Cummings, 1997; Cummings et al.,
1994) identiﬁed psychopathology for people with
dementia in care homes. It assesses the presence and
occupational disruptiveness of 12 behaviours, such
as agitation/aggression, anxiety, and disinhibition.
The frequency (within the past 2 weeks) and severity
of each behaviour are rated on a four-point (1–4)
and three-point (1–3) Likert scale, respectively. A
score is then calculated for each behaviour by mul-
tiplying the severity and frequency score (1 – 12).
A total score is then calculated by adding the scores
of all 12 subscales. A composite score comprising
agitation/aggression, irritability/lability, disinhibi-
tion and aberrantmotor behaviour accounts for 60%
of the variance of a total CMAI score (Wood et al.,
2000). The measure showed internal consistency of
α= .63 at baseline.
QUALITY OF LIFE IN LATE-STAGE DEMENTIA
The Quality of Life in Late-Stage Dementia
(QUALID) scale (Weiner et al., 2000) measures
11 observable behaviours thought to indicate qual-
ity of life such as ‘enjoys interacting or being with
others’. Each behaviour is scored on a ﬁve-point
Likert scale, lower scores indicate higher quality of
life. The measure is based on observations made
over the previous 7 days. Scores previously corre-
lated with the NPI (r= .40, p= .001; Weiner et al.,
2000), although not the CMAI (r= .19, p > .05;
Benhabib et al., 2013). The NPI-NH showed inter-
nal consistency of α= .74 at baseline.
FUNCTIONAL ASSESSMENT STAGING OF
ALZHEIMER ’S DISEASE
The Functional Assessment Staging of Alzheimer’s
Disease (FAST; Reisberg, 1988) records how
severely dementia affects individuals’daily function-
ing. Scores range from 1 (no dementia) to 7 (severe
dementia), with levels 6 and 7 having sub-levels,
focusing on deﬁcits associatedwith personal care and
communication. It was completed by a researcher
through interview with a staff proxy.
MISSING DATA
The levels of missing data were relatively high by the
second follow up (43.8%), due to loss to follow up
across 16-months of the trial (see Table 2). During
data analysis, missing data were identiﬁed and re-
coded before being incorporated or excluded from
all analyses. For the incremental validity and dis-
criminant validity analyses all missing data recorded
from each scale were excluded from the analysis.
When performing correlation analyses between the
PAS and CMAI-O, multiple imputation was used
(Rubin, 1987). This technique creates complete
data sets by generating several possible values for
any missing values. Analyses are conducted across
all of these data sets and outputs provide estimates
for each data set about the results that would have
been expected if there had been no missing values in
the original data set. In the present study, ﬁve data
imputations were created.
Furthermore, the CMAI-O was only completed
for participants who were in a communal area
Table 2. Loss to follow up (of 726 registered residents
at baseline)
6 MONTHS 16 MONTHS
...........................................................................................................................................................
CMAI questionnaire (staff proxy completed)
Received 587 (80.9%) 408 (56.2%)
Not received 139 (19.1%) 318 (43.8%)
Reasons not received
Died 115 (15.8%) 264 (36.4%)
Moved out 21 (2.9%) 51 (7%)
Withdrew 1 (0.1%) 1 (0.1%)
Other 9 (1.2%) 3 (0.4%)
4 A. W. Grifﬁths et al.
https://doi.org/10.1017/S1041610219000279
Downloaded from https://www.cambridge.org/core. King's College London, on 22 May 2019 at 11:29:20, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
during data collection (either AM, PM, or both).
The number of participants with completed CMAI-
O at each time point and reasons why people were
not in a communal area of the care home were
recorded (see Table 3).
Data Analysis
Data manipulation, analyses and graphical visuali-
sations were performed in IBM SPSS 24. Prior
to performing inferential statistical analyses, each
dataset was assessed for parametric assumptions.
A skewed distribution was consistently observed
across all data, suggesting that scores were predom-
inantly weighted at the lower end of each scale. This
was expected as the majority of residents within care
homes score lowly on neuropsychiatric outcome
measures; whilst only aminority of residents typically
score highly. In order to account for this non-normal
data, parametric bootstrapping was performed on all
analyses (seeDavison andHinkley, 1997). Data were
deemed to meet all other parametric assumptions.
Several forms of validity were tested; criterion
validity, incremental validity and discriminant valid-
ity. Criterion validity refers to the degree of corre-
lation between a proposed novel measure and a
pre-existing, validated assessment that targets the
same phenomenon. It is important that a new mea-
sure demonstrates criterion validity as it assures
researchers and practitioners that any results derived
can be assumed to be consistent with alternative
methods of assessment. Incremental validity is used
to determine whether a new measure increases the
predictive ability beyond that provided by an existing
tool. It is important to demonstrate this form of
validity as it demonstrates that a measure elicits
additional information relative to other measures.
Discriminant validity illustrates whether scores on a
scale are truly independent of scores on another
scale that measures distinctly different phenomena.
Previous evidence has found no correlation between
agitation and apathy in a sample of nursing home
residents living with dementia (Mouriz-Corbelle
et al., 2017). Therefore, we hypothesised that the
CMAI-O would be unrelated to the NPI Apathy
subscale if discriminant validity is high.
Results
Sample
The baseline sample consisted of 726 participants,
with an average age of 85 (range: 57–102). The ma-
jority of participants were female (536; 73.8%) and
identiﬁed asWhite British (702; 96.7%). Participant
dementia severity, as rated by the FAST, spannedTa
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mild cognitive impairment (6; 1%), mild dementia
(95; 13.6%), moderate dementia (74; 10.6%),
moderate/severe dementia (380 ;54.5%) and severe
dementia (142; 20.4%), with data missing for
29 participants (3.9%). The average score on the
CMAI was 47.35 points (standard deviation=
18.40) and average score on the NPI was 14.18
(SD= 14.69). Of these participants, 451 (62%) had
a completed CMAI-O for AM, and 470 (65%)
for PM.
At 6 months, the sample consisted of 587 parti-
cipants. The average score on the CMAI was 45.35
(standard deviation= 16.32). Of these participants,
369 (62%) had a completed CMAI-O for AM and
357 (61%) for PM. At 16 months, the sample
consisted of 408 participants. The average score on
the CMAI was 44.38 (standard deviation= 16.72).
Of these participants, 231 (56%) had a completed
CMAI-O for AM and 221 (54%) for PM.
Preliminary analyses
The prevalence of each symptom at baseline, mea-
sured using the CMAI and CMAI-O can be seen
in Table 4. Within this table, for the CMAI, only
items that were present ‘several times a week’ or
more were included, in order to be comparable with
the CMAI-O. This is due to the CMAI-O being
completed during one single day; therefore, items
that are displayed once per week or less were unlikely
to be displayed during a single day observation.
Generally, levels of agitation were lower for the
CMAI-O, with the exception of ‘performing repeti-
tious mannerisms’, which was seenmore commonly.
Correlations between the CMAI-O and the
CMAI, PAS and NPI, at each time point were also
conducted (see Table 5). Pearson correlations for
the CMAI-O and the CMAI as scored by the staff
proxy were signiﬁcant: baseline r= .44, 6 months
r= .23 and 16months r= .28 (all p< .001). TheNPI
Agitation subscale had a weak but statistically sig-
niﬁcant correlation with the CMAI-O at baseline
and 6 months (r= .38, p=< .001 and r= .12,
p= .021), however no signiﬁcant correlation was
found between the two measures at 16 months
(r= .09, p= .199). Finally, both the AM and the
PM scores for the PAS showed a signiﬁcant corre-
lation with total CMAI-O scores across all time
points, with a signiﬁcance of p=< .001.
To understand whether scores on the CMAI-O
were related to scores on another scale measuring
agitation, correlations were calculated between this
and the PAS. There is no existing evidence of
validation of the CMAI and the PAS. Given the
PAS is the only existing observational measure of
agitation it was used to compare to the CMAI-O,
to establish criterion validity. A partial correlation
was completed with bootstrapping to account for
non-normally distributed data, controlling for the
data collection time point (baseline/6-month fol-
low up/16-month follow up) and the time of day
Table 4. Proportion of residents experiencing
symptoms associated with agitation at baseline
(% of those with both Cohen Mansfield Agitation
Inventory-Observational and Cohen Mansfield
Agitation Inventory completed)
SYMPTOM CMAI-O CMAI
...........................................................................................................................................................
Pacing, aimless wandering 15 32
Inappropriate dress or disrobing 2 11
Spitting (including at meals) 1 7
Cursing/verbal aggression 8 14
Constant unwarranted request for
attention/help
4 15
Repetitive sentences/questions 9 27
Hitting (including self ) 1 8
Kicking 1 6
Grabbing onto people 2 10
Pushing 2 6
Throwing 1 3
Strange noises (weird laughter or crying) 11 13
Screaming 1 10
Biting 1 2
Scratching 1 6
Trying to get to a different place 3 10
Intentional falling 1 1
Complaining 10 14
Negativism 4 11
Eating/drinking inappropriate substances 1 2
Hurting self or others 1 1
Handling things inappropriately 4 4
Hiding things 0 5
Hoarding things 1 4
Tearing things/destroying property 1 2
Performing repetitious mannerisms 22 15
Making verbal sexual advances 1 2
Making physical sexual advances 1 1
General restlessness 16 24
Table 5. Correlation between measures completed at
each time point
MAI-O
BASELINE
6
MONTHS
16
MONTHS
...........................................................................................................................................................
CMAI .436* .226* .276*
NPI (Agitation) .382* .121* .085
PAS (AM) .583* .825* .770*
PAS (PM) .638* .479* .540*
*signiﬁcant at p < 0.01 **CMAI-O – Cohen-Mansﬁeld Agitation
Inventory – Observational; CMAI – Cohen Mansﬁeld Agitation
Inventory; NPI – Neuropsychiatric Inventory; PAS – Pittsburgh
Agitation Scale
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(AM or PM) when both were completed. When
controlling for time point and the time of day com-
pleted, a signiﬁcant partial correlation was found
(r= .80, p=<.001). Additionally, we compared
CMAI-O scores to the NPI Agitation subscale.
Whilst not an observational measure, it represents
a psychometric tool validated to measure agitation
in nursing home residents, thus a signiﬁcant corre-
lation between this and the CMAI-O would support
criterion validity. A partial correlation analysis of
the CMAI-O and the NPI Agitation subscale, con-
trolling for data collection time point, found a small
but signiﬁcant relationship between the measures
(r= .24, p=<.001).
To assess whether the CMAI-O increased the
predictive ability beyond that provided by an existing
method of assessment, we hypothesised that agita-
tion as measured by the CMAI-O would predict
quality of life as measured by the QUALID, above
the prediction from scores on the FAST. It has been
suggested in previous studies that functional status
signiﬁcantly impacts the quality of life of a person
living with dementia (e.g. Andersen et al., 2004)
with those with more severe dementia experiencing
poorer quality of life.
In step one of a hierarchal multiple regression,
scores on the FASTwere included as a predictor of
quality of life. The FAST score signiﬁcantly pre-
dicted the quality of life score across all time points,
baseline (β= .21, p < .001), 6 months (β= .202,
p= .001) and 16 months (β= .198, p= .006). In
step two of the analysis, when the CMAI-O score
was also included as a predictor, an R2 change
of .095 (R2= .139, F(2, 390)= 66.87, p <.001)
was observed at baseline, an R2 change of .027
(R2= .068, F(2, 286)= 33.7, p<.001) at 6-months
and an R2 change of .042 (R2= .082, F(2, 191)=
32.12, p<.001) at 16 months. The FAST re-
mained signiﬁcant at each of these time points
also [6 months (β= 3.45, p= .001), 16 months
(β= 3.09, p= .002)]. These analyses demonstrated
that the observational CMAI had incremental pre-
dictive value in the measurement of quality of life
beyond levels that could be predicted by partici-
pants’ stage of dementia, as determined by func-
tional status (FAST).
To establish whether the CMAI-O failed to
correlate with ameasure that should be conceptually
unrelated, bootstrapped correlation analyses be-
tween the CMAI-O and all NPI subscales were
conducted, controlling for the data collection time
point. We hypothesized that the CMAI-O would
show no relationship with the NPI Apathy subscale.
No relationship was found between the CMAI-O
and NPI Apathy subscales, when controlling
for time point (r= .004, p= .902). This suggests
that agitation as measured by the CMAI-O is
completely unrelated to apathy, in line with previous
research.
Discussion
The present study describes the development and
validation of the CMAI-O. This tool assesses agita-
tion over a shorter period than the original CMAI,
can be completed by an independent observer rather
than relying on proxy reports and therefore could
form part of an agitation assessment battery for
research, including clinical trials.The psychometric
properties of the CMAI-O were examined. Scores
on the CMAI-O correlated with scores on the
CMAI, PAS and NPI-NH, and the tool had incre-
mental predictive value when measuring quality of
life beyond levels predicted by functional status. No
relationship was found between the CMAI-O and
NPI Apathy subscale, suggesting that agitation as
measured by the CMAI-O is completely unrelated
to apathy. The internal consistency of the CMAI-O,
whilst being adequate, suggested that there may be
issues with the items within the scale. Further exam-
ination of this is required, to establish whether this
was caused by general low levels of agitation within
our sample, or issues within the measure.Within the
current study, we sought to assess the psychometric
properties of an alternative method of administra-
tion, therefore we have not suggested reﬁnement of
the CMAI-O items.
To identify whether the CMAI-O identiﬁed
behaviours typically associated with agitation com-
parisons between the CMAI-O and CMAI were also
conducted. Scores on theCMAI-Owere consistently
slightly lower than those on the CMAI. This may be
due to the restricted locations and time periods of
observation. For example, observations took place in
the communal areas therefore agitated behaviours
in other areas were not recorded, in particular dur-
ing personal care. Previously, personal care activities
including bathing and toileting, particularly when
initiated by a caregiver rather than the resident
themselves, have been found to signiﬁcantly increase
agitation behaviours (Cohen-Mansﬁeld et al., 1992).
There are several limitations with the present
research. One difﬁculty when using observational
methods for assessing agitation is that many beha-
viours do not occur often, therefore long observa-
tions are sometimes required to detect behaviours.
This is especially true for the less common beha-
viours like aggression, which are some of the most
important in terms of impact on others (Cohen-
Mansﬁeld, 1996). A standardised period of 5 hours
within a single day in this study provided data
that was adequately correlated with alternative
proxy measures and, therefore, is the recommended
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minimum observation period for use of the CMAI-
O. Secondly, we recruited participants from 50 care
homes in three areas of England, which may not
represent average care homes across the UK. For
example, those under admissions bans due to
breaches of statutory regulations were not eligible
to participate and those approached but not inter-
ested in taking part in research did not consent
to take part. The levels of agitation seen in the
present sample were lower than previous samples
(e.g. Zuidema et al., 2007). This may reﬂect im-
proved understanding of how to effectively manage
behaviours associated with agitation by care home
staff over recent years. Understanding these as a
reﬂection of unmet needs rather than symptoms of
dementia is becoming a more common approach
and recent research has found lower levels of agita-
tion amongst people living with dementia in care
homes (Livingston et al., 2017). Furthermore, the
average CMAI score in the present study was sim-
ilar to that of participants in another recent psycho-
social clinical trial (Ballard et al., 2016). However,
comparing levels of agitation in this study to those
reported in earlier care home studies identiﬁed
lower levels in this sample generally. For example,
16% of individuals experienced general restless-
ness, in comparison to 44% of individuals in the
Netherlands (Zuidema et al., 2007), although our
sample was comparable to the 22% of individuals
who experienced general restlessness within a
Norwegian sample (Testad et al., 2007). However,
it may be that given the relationship between agita-
tion and poor quality care, individuals living in care
homes where there are breaches of statutory regula-
tions, such as unsafe stafﬁng levels, might experi-
ence greater levels of agitation, and such individuals
were not recruited in the present study as their care
homes were ineligible to participate. Additionally,
we only observed participants in communal areas,
whichmay have impacted on levels of agitation. This
may be particularly relevant as some of the measures
completed by staff proxy informants included spe-
ciﬁc questions about personal care, which are not
observed due to issues around privacy and dignity.
By developing the CMAI-O we have addressed
the disadvantage of the CMAI relating to potential
reporting biases from proxy reporters. However,
observational measures of agitation also have limita-
tions. Levels of agitation observed by the CMAI-O
were generally lower than those reported by care
staff members in the CMAI, although scores on the
two were signiﬁcantly correlated. It may be that staff
proxies over-report the prevalence of these beha-
viours on the CMAI, particularly if they ﬁnd the
behaviours difﬁcult to support. Alternatively the
CMAI-O may miss some agitation due to its use
in this study only in communal areas during the
daytime. Research indicates higher levels of agita-
tionmay be seen in the evenings and during personal
care (e.g. Sloane et al., 2004). However, the CMAI-
O does have the beneﬁt of using continual observa-
tion over two sustained periods, which may offer a
more accurate picture of agitation than measures
that use short time-sampling observations. Addi-
tionally, observer fatigue is a concern with longer
observation periods and one which should be con-
sidered. Therefore, further research on optimal ob-
servation length and time(s) of day when using the
CMAI-O is required, as well as exploration of ethical
and practical issues around the potential for obser-
vations to be conducted in other areas where care
may be delivered. Researchers have rightly ques-
tioned the accuracy of recall of agitated behaviours
by staff members working in care homes, due to the
impact of caregiver burden. Care staff reporting a
lower burden have been found to provide higher
quality of life ratings than those experiencing more
caregiver burden (Graske et al., 2014). One possible
explanation for this is that care staff experiencing
more burden also expect residents to be experienc-
ing this burden (Graske et al., 2014). Alternatively,
it may be that those experiencing more burden are
less able to see positive aspects of residents’ lives.
However, there is currently very little research exam-
ining this amongst formal care staff. A systematic
review of the relationship between family caregiver
distress and quality of life ratings concluded that
family caregivers who reported experiencing more
stress associated with caregiving provided more
negative reports of their relative’s quality of life
(Neumann et al., 2000). However, more recently
no relationship has been found between family care-
giver distress and their proxy quality of life ratings
(Sheehan et al., 2012). Furthermore, there is scope
for inﬂuence by interpretation or perceptual biases
of individual proxies. For example, a resident whose
physical mobility has improved following an exercise
intervention and who is spendingmore time walking
may be noted as ‘wandering’ (Brett et al., 2017)
by care home staff. This may be due to a perception
that residents who are not sitting are more problem-
atic to care for, or that ‘wandering’ is a common
problem in dementia and therefore all walking be-
haviours must be wandering. Perceiving or inter-
preting this behaviour as wandering would indicate
an increase in agitation when completing the CMAI,
when the behaviour is instead walking that reﬂects
an increase in physical ability and activity. Use of
the CMAI-O, by trained researchers who receive
instruction on how to observe and interpret resi-
dent behaviours may allow a more objective under-
standing of the behaviour of individuals, through
concentrated observation of them over a substantial
period of time. This may provide a more accurate
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measure of agitation than untrained staff recall of
behaviours over the previous 2 weeks. Future re-
search should consider the inﬂuence of proxy re-
porters and their subjective experiences on research
outcomes.
Furthermore, a single researcher can complete
the CMAI-O for multiple participants over several
time points, whereas it is particularly difﬁcult to
recruit staff proxies for multiple time points, based
on turnover and shift patterns. In addition the use of
staff proxies to report on agitation of a 2-week period
raises concerns about accuracy reporting, since they
work shifts and even when on duty do not always
spend long periods of time with individual residents.
Therefore, assumptions about frequency of agitated
behaviours may be made on based on intensity over
a short period or reports of disruptiveness from
colleagues. In one recent study, to overcome this,
staff members completed a tally score of the CMAI
at the end of each shift for a 2-week period (Brett
et al., 2017). The CMAI-O addresses this poten-
tial reporting bias, as a researcher captures all be-
haviours across a single day, leading to decreased
likelihood of over or under-reporting of agitated
behaviours. However, observation on a single day
does limit ability to observe less common but poten-
tially impactful behaviours and therefore, further
research is needed to examine the test-retest reli-
ability of the CMAI-O and establish the optimal
periods over which to use the measure to most
accurately capture the full extent and range of agi-
tated behaviours. Future research should also
extend the validation of the CMAI-O to conﬁrm
the factor structure of the measure amongst indivi-
duals experiencing higher levels of agitation and
establish whether it is suitable for use in other
settings, such as hospital wards, or with other po-
pulations such as individuals living with severe and
enduring mental health problems, where agitation is
a concern.
The CMAI-O offers a novel approach for evaluat-
ing the presence of behaviours associated with agita-
tion amongst people with dementia in care homes
(both residential and nursing) within research and
practice. The CMAI-O may be particularly useful to
include in research where the CMAI is the primary
outcome, since it may provide a measure of potential
performance or reporting bias from staff members
who cannot be blinded to treatment arm. Moreover,
as an observational measure of agitation, the CMAI-
O offers a more suitable observational measure than
the PAS or ABS because its items are directly aligned
to the CMAI and thus the results are complementary
to those obtained on the CMAI. As such, future
researchers will be able to conﬁdently provide
composite CMAI scores using information from
both proxy-informant and researcher observations.
Conclusion
In conclusion, this initial validation of the CMAI-O
has demonstrated that the tool is appropriate for use
with people living with dementia in care homes. The
tool provides a complementary or alternative to
measure to staff proxy completed measures of agi-
tation. This may be particularly valuable when eval-
uating care home interventions. It is hoped that
the development of the CMAI-O leads to increased
use of independent assessment to understand beha-
viours associated with agitation amongst people
living with dementia in care homes and its use as
an outcomemeasure to evaluate change in agitation.
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